COMMON MAPS
Map version new-york activity top-down
Main site Contact
Menu
↑ parent activity group ·
research dossier

NATIONAL HARM REDUCTION COALITION
NEW YORK, NY · EIN 943204958 · Form 990 · FY2024 · NTEE E30 · Health Care · Medium ($1M-$10M)
revenue
$8.6M
expenses
$6.6M
net assets
$5.2M
employees
49
volunteers
8
program ratio
86%
mission · from form 990

THE MISSION OF THE NATIONAL HARM REDUCTION COALITION (NHRC) IS TO PROVIDE NATIONAL EDUCATION ON PREVENTION AND INTERVENTION TO REDUCE DRUG RELATED HARM.

profile · synthesized from sources

National Harm Reduction Coalition (NHRC) is a New York-based nonprofit focused on reducing drug-related harm through education, policy advocacy, and coalition-building. The organization works to improve public health outcomes for people who use drugs by advancing harm reduction policies and practices at local, state, national, and international levels. NHRC also organizes conferences that serve as key forums for networking and knowledge exchange among harm reduction practitioners and stakeholders.

irs program accomplishments · form 990 part iii · fy2024

What they reported doing

  1. #1 primary $489K
    POLICY AND ADVOCACY - NHRC'S POLICY DEPARTMENT ADVOCATES FOR POLICIES TO IMPROVE THE HEALTH OF PEOPLE AND COMMUNITIES IMPACTED BY SUBSTANCE USE. OUR ADVOCACY SEEKS TO CREATE CHANGES AT THE LOCAL, STATE, NATIONAL, AND INTERNATIONAL PUBLIC HEALTH FORUMS THROUGH A RANGE OF STRATEGIES THAT INCLUDE DIRECT ADVOCACY WITH POLICY MAKERS, POLICY ANALYSIS, EDUCATION AND COALITION BUILDING.
  2. #2 $19K
    CONFERENCES - NHRC SPONSORS AND ORGANIZES NATIONAL, REGIONAL AND LOCAL CONFERENCES. NHRC CONFERENCES PROVIDE A CRITICAL AND UNIQUE FORUM FOR THE EXPLORATION AND DEVELOPMENT OF HARM REDUCTION PRACTICE, THEORY AND POLICY AND SERVE AS CRUCIAL NETWORKING SPACES FOR INDIVIDUALS AND ORGANIZATIONS WORKING ACROSS DIFFERENT FIELDS, INCLUDING HEALTH, TREATMENT, RECOVERY, AND HOUSING, AMONG OTHERS.
named programs · 3 · from sources

What they call their work

Community Organizing
Supports grassroots efforts to advance harm reduction by organizing communities impacted by substance use and building collective power to influence systemic change.
Conferences
Organizes national, regional, and local conferences that serve as forums for developing harm reduction practice, policy, and theory, and provide networking opportunities for professionals and organizations in the field.
Policy and Advocacy
Advocates for public health policies that reduce drug-related harm through direct engagement with policymakers, policy analysis, education, and coalition-building at local, state, national, and international levels.
activities · 5 groups

What they do

  • Opioid Harm Reduction Services 4 activities
    • Distributing harm reduction supplies
      Distributes naloxone, sterile syringes, and fentanyl testing supplies to people who use drugs through direct programs and Syringe Services Programs (SSPs), including distributing over 50,000 kits in 2022 and supporting naloxone distribution through The DOPE Project.
    • Implementing state and regional harm reduction initiatives
      Runs statewide harm reduction programs in California and New York, including collaboration with ED-BRIDGE to expand 24/7 buprenorphine access to 52 hospital sites in California, and conducts on-the-ground initiatives in various regions to support people who use drugs.
    • Operating the Naloxone Finder and supporting naloxone access
      Operates and maintains the Naloxone Finder, a bi-monthly updated resource map that helps people locate community-based naloxone access points across the United States, and provides promotional materials to support its dissemination.
    • Providing harm reduction training and technical assistance
      Delivers in-person and virtual training, learning resources, and technical assistance to community-based organizations and peer educators on implementing harm reduction practices. Conducted over 110 trainings and thousands of hours of training across 36 states in 2022, supporting hundreds of organizations.
  • Substance Use Policy Advocacy & Public Education 1 activity
    • Advancing harm reduction policy and advocacy
      Conducts policy advocacy and community organizing to promote equal access to health care and human services for people who use drugs, including direct engagement with policymakers, policy analysis, coalition building, and public narrative shifting at local, state, national, and international levels. Achieved syringe access policy victories in multiple states and secured over $15 million in funding for syringe service programs in California.
  • HIV Research and Advocacy Funding 1 activity
    • Funding grassroots and regional harm reduction projects
      Provides grant funding to support grassroots and regional harm reduction efforts, including awarding $5.3 million to 42 projects through the HepConnect Initiative and funding 34 CHRI grantees that served over 66,600 people who use drugs, achieved 9,000 program enrollments, and referred nearly 6,000 to MOUD treatment.
  • Scientific Conference & Symposium Management 1 activity
    • Organizing national and regional harm reduction conferences
      Sponsors and organizes the only national harm reduction conference in the United States, along with bi-annual regional conferences, bringing together thousands of participants to advance harm reduction practice, policy, and networking across health and recovery fields.
  • HIV/AIDS Prevention and Support Services 1 activity
    • Running the HepConnect Initiative to combat hepatitis C
      Implements the HepConnect Initiative to respond to rising hepatitis C rates in Greater Appalachia through targeted harm reduction programs and services.
financials · form 990 · fy2024
revenue
Total revenue$8.61M
Contributions & grants$7.83M91%
Program service revenue$461K5%
Investment income$1K0%
Other revenue$318K
expenses
Total expenses$6.58M
Program expenses86%
Admin / overhead11%
Fundraising3%
Salaries & benefits$3.92M
Grants paid out$187K
Largest expense lineCompensation
balance sheet
Total assets$6.28M
Cash$1.60M
Investments$0
Liabilities$1.09M
Net assets$5.19M
Liquid reserves2.9 mo
4 years on record · 2020–2024 · YoY revenue -20.7%
leadership · form 990 part vii · fy2024

Who runs it

paid leadership · 5
NameTitleHours/wkCompensation
LAURA GUZMAN EXECUTIVE DIRECTOR 40 $188K
KEILA NUNEZ CONTROLLER 40 $166K
SONDRA GROVER CHIEF FINANCIAL OFFICER 40 $161K
REGINA JEAN-BAPTISTE CHIEF HR & OPERATIONS OFFICER 40 $143K
ANTHONY SALANDY CHIEF PROGRAM & BUSINESS STRATEGY OFFICER 40 $128K
board members · 8
  • DEBORA UPEGUI-HERNANDEZ — DIRECTOR
  • JEAN-PAUL NGAMBI — TREASURER
  • JULIE STAMPLER — DIRECTOR
  • LUCY TRIESHMANN — BOARD CO-CHAIR
  • MARGARET DENISE BORDEAUX — DIRECTOR
  • MARLENE MARTIN — SECRETARY
  • RAJANI GUDLAVALLETI MPP — BOARD CO-CHAIR
  • SHAN HICKS — DIRECTOR
relationships · 38

Who they work with

  • AIDS United Partner — Government, foundation, or corporate supporter of the National Harm Reduction Coalition
  • Arnold Ventures Funder — Foundation funder of the National Harm Reduction Coalition
  • Broadway Cares/Equity Fights AIDS Funder — Corporate or foundation funder supporting the National Harm Reduction Coalition
  • CHRI grantees Partner — Organizations receiving funding and support through NHRC’s California Harm Reduction Initiative
  • California Department of Public Health Government — Government agency providing support to the National Harm Reduction Coalition
  • California Regional Initiatives Partner — Provides harm reduction resources for people in California who use drugs.
  • Center for Disease Control and Prevention (CDC) Government — Federal public health agency supporting the National Harm Reduction Coalition
  • Comer Family Foundation Funder — Private foundation funder of the National Harm Reduction Coalition
  • Drug Policy Alliance Partner — Co-organized a statewide coalition in California to secure funding for syringe service programs.
  • ED-BRIDGE Partner — Partnered to expand 24/7 buprenorphine access to 52 hospital sites in California.
  • Elton John AIDS Foundation Funder — International foundation supporting the National Harm Reduction Coalition
  • Fishman Family Foundation Funder — Private foundation providing financial support to the National Harm Reduction Coalition
  • Gilead Funder — Corporate sponsor supporting the National Harm Reduction Coalition
  • H Van Ameringen Foundation Funder — Foundation funder focused on public health, supporting the National Harm Reduction Coalition
  • HepConnect Partner — Collaborates on responding to rising hepatitis C rates in Greater Appalachia.
  • Joybyte Partner — Website development partner for NHRC
  • Judson Memorial Church Partner — Religious institution supporting the National Harm Reduction Coalition
  • Lighthouse Learning Collective Partner — Collaborates on creating safer spaces with LGBTQ+/TGNC+ communities.
  • Lighthouse Learning Collective Partner — Collaborates to create safer spaces with LGB/TGNC+ people in New York.
  • Local harm reduction programs Partner — Connects volunteers and community members with local harm reduction programs.
  • MAC AIDS Foundation Funder — Corporate foundation funder supporting the National Harm Reduction Coalition
  • NASEN Partner — Collaborates with NASEN to direct users to local syringe access programs via its website map.
  • NASTAD Partner — Public health organization collaborating with the National Harm Reduction Coalition
  • NEXT Distro Partner — Partners with NEXT Distro to facilitate mail-based naloxone access for people who use drugs lacking local resources.
  • NYC Health Government — Municipal public health department supporting the National Harm Reduction Coalition
  • National Harm Reduction Coalition Network — Organization advancing a national movement for harm reduction and social justice.
  • National Harm Reduction Coalition Policy Department Partner — Internal unit responsible for policy advocacy and community organizing efforts.
  • New York State Department of Health Government — State government agency supporting the National Harm Reduction Coalition
  • Open Society Foundation Funder — Major philanthropic foundation supporting the National Harm Reduction Coalition
  • PeerUp Partner — Collaborates to build a nationwide hub for peer support in harm reduction.
+ 8 more
strategies · 5

How they approach the work

Named approaches extracted from this org’s sources. Where others share an approach, follow it to see the full set of orgs running it.

  • Meeting People Where They Are
    methodology: meeting-people-where-they-are
    By offering a spectrum of approaches—including safer use, managed use, and abstinence—the organization increases engagement and reduces harm because it respects individuals' current relationships with drug use and avoids imposing readiness for change.
  • Multilevel Policy Advocacy and Convening
    methodology: multi-level_policy_advocacy
    By combining direct advocacy, policy analysis, public education, and coalition building across governance levels, the organization advances systemic change because sustained policy impact requires coordinated pressure and knowledge-sharing across sectors.
  • Peer-Led Harm Reduction
    methodology: peer-led-harm-reduction
    By centering people who use drugs as leaders, designers, and deliverers of harm reduction services, the organization improves program relevance and effectiveness because lived experience produces trust, cultural competence, and sustainable behavior change.
  • Power-Shifting to Impacted Communities
    methodology: power_shifting
    By shifting decision-making power and resources to communities most impacted by structural violence and racialized drug policies, the organization creates more equitable and effective solutions because those closest to the problem possess the insight and moral authority to lead change.
  • Structural Harm Reduction
    methodology: structural_harm_reduction
    By addressing root causes such as racism, criminalization, stigma, and marginalization, the organization reduces drug-related harm more effectively than individual-level interventions alone, because these structural drivers determine health outcomes at scale.